Moderator Robert A. Figlin, MD, introduces a panel discussion focuses on therapeutic advances in the treatment of renal cell cancer (RCC), with an emphasis on key case studies in community oncology practice. The discussion includes expert analysis from Janice P. Dutcher, MD, Charles A. Henderson, MD, Daniel Heng, MD, MPH, and Brian I. Rini, MD.
To view more from this discussion, visit [ Ссылка ]
